EpicentRx Inc is a biotechnology company based in La Jolla, CA, specializing in the development of innovative cancer therapies. Led by a team of experienced professionals, including Chief Executive Officer Dr. Tony Reid and Chief Scientific Officer Dr. Franck Brinkhaus, the company is dedicated to advancing its pipeline of cutting-edge technologies, such as the AdAPT Platform and PRETECT Platform, to revolutionize cancer treatment.
With a focus on viral therapy and a commitment to scientific excellence, EpicentRx Inc aims to bring novel solutions to patients in need. Their team, which includes Chief Medical Officer Dr. Bryan Oronsky and Vice President of Viral Therapy Dr. Chris Larson, is dedicated to pushing the boundaries of cancer research and developing innovative therapies that have the potential to transform the lives of patients worldwide.
Generated from the website